Anthem Blue Cross and Blue Shield | Medicare AdvantageJanuary 28, 2025
Eye Exam for Patients with Diabetes (EED) 2025
Healthcare Effectiveness Data Information Set® (HEDIS) is a widely used set of performance measures developed and maintained by NCQA. These are used to drive improvement efforts surrounding best practices.
HEDIS measure
This measure assesses the percentage of patients 18 to 75 years of age with diabetes (types 1 or 2) who had a retinal eye exam.
Numerator
Medicare Advantage patients ages 18-75 with diabetes who had a retinal or dilated eye exam by optometrist or ophthalmologist in 2025 OR a negative retinal or dilated eye exam by an eye care professional in 2024
Denominator
Patients 18-75 years of age with type 1 or type 2 diabetes
Refer to attachment to view full details
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CR-075522-24-CPN74976
ATTACHMENTS: Eye Exam for Patients with Diabetes (EED) 2025 (pdf - 0.53mb)
To view this article online:
Visit https://providernews.anthem.com/virginia/articles/eye-exam-for-patients-with-diabetes-eed-2025-23861
Or scan this QR code with your phone